
Virginia Gambale sells $152,512 in Jamf Holding Corp. stockResearchers launch “moonshot” to cure blindness through eye transplants
No. 25 Illinois' TD with four seconds left upends Rutgers
Concurrent Gainers: 10 midcap stocks that gain for 5 days in a rowNEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Terran Orbital Corporation (NYSE: LLAP). Shareholders who purchased shares of LLAP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/terran-orbital-corporation-loss-submission-form/?id=113430&from=3 CLASS PERIOD: August 15, 2023 to August 14, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) it would take much longer than defendants had represented to investors and analysts for Terran to convert its contracts with its customers (collectively, “Customer Contracts”) into revenue and free cash flow; (ii) Terran did not have adequate liquidity to operate its business while waiting for the Customer Contracts to generate revenue and free cash flow; (iii) Terran had concealed the true scope and severity of its dire financial situation; and (iv) as a result of the foregoing, Terran’s public statements were materially false and misleading at all relevant times. DEADLINE: November 26, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/terran-orbital-corporation-loss-submission-form/?id=113430&from=3 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of LLAP during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is November 26, 2024. There is no cost or obligation to you to participate in this case. WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: The Gross Law Firm 15 West 38th Street, 12th floor New York, NY, 10018 Email: dg@securitiesclasslaw.com Phone: (646) 453-8903As part of a national “moonshot” to cure blindness, researchers at the CU Anschutz Medical Campus will receive as much as $46 million in federal funding over the next five years to pursue a first-of-its-kind full eye transplantation. “This is no easy undertaking, but I believe we can achieve this together,” said Dr. Kia Washington, the lead researcher for the University of Colorado-led team, during a press conference Monday. “And in fact I’ve never been more hopeful that a cure for blindness is within reach.” The CU team was one of four in the United States that received funding awards from the federal Advanced Research Projects Agency for Health , or ARPA-H. The CU-based group will focus on achieving the first-ever vision-restoring eye transplant by using “novel stem cell and bioelectronic technologies,” according to a news release announcing the funding. The work will be interdisciplinary, Washington and others said, and will link together researchers at institutions across the country. The four teams that received the funding will work alongside each other on distinct approaches, though officials said the teams would likely collaborate and eventually may merge depending on which research avenues show the most promise toward achieving the ultimate goal of transplanting an eye and curing blindness. Dr. Calvin Roberts, who will oversee the broader project for ARPA-H, said the agency wanted to take multiple “shots on goal” to ensure progress. “In the broader picture, achieving this would be probably the most monumental task in medicine within the last several decades,” said Dr. Daniel Pelaez of the University of Miami’s Bascom Palmer Eye Institute, which also received ARPA-H funding. Pelaez is the lead investigator for that team, which has pursued new procedures to successfully remove and preserve eyes from donors, amid other research. He told The Denver Post that only four organ systems have not been successfully transplanted: the inner ear, the brain, the spinal cord and the eye. All four are part of the central nervous system, which does not repair itself when damaged. If researchers can successfully transplant the human eye and restore vision to the patient, it might help unlock deeper discoveries about repairing damage to the brain and spine, Pelaez said, as well as addressing hearing loss. To succeed, researchers must successfully remove and preserve eyes from donors and then successfully connect and repair the optical nerve, which takes information from the eye and tells the brain what the eye sees. A team at New York University performed a full eye transplant on a human patient in November 2023, though the procedure — while a “remarkable achievement,” Pelaez said — did not restore the patient’s vision. It was also part of a partial face transplant; other approaches pursued via the ARPA-H funding will involve eye-specific transplants. Washington, the lead CU researcher, said she and her colleagues have already completed the eye transplant procedure — albeit without vision restoration — in rats. The CU team will next work on large animals to advance “optic nerve regenerative strategies,” the school said, as well as to study immunosuppression, which is critical to ensuring that patients’ immune systems don’t reject a donated organ. The goal is to eventually advance to human trials. Pelaez and his colleagues have completed their eye-removal procedure in cadavers, he said, and they’ve also studied regeneration in several animals that are capable of regenerating parts of their eyes, like salamanders or zebra fish. His team’s funding will focus in part on a life-support machine for the eye to keep it healthy and viable during the removal process. InGel Therapeutics, a Massachusetts-based Harvard spinoff and the lead of a third team, will pursue research on 3-D printed technology and “micro-tunneled scaffolds” that carry certain types of stem cells as part of a focus on optical nerve regeneration and repair, ARPA-H said. ARPH-A, created two years ago, will oversee the teams’ work. Researchers at 52 institutions nationwide will also contribute to the teams. The CU-led group will include researchers from the University of Southern California, the University of Wisconsin, Indiana University and Johns Hopkins University, as well as from the National Eye Institute . The teams will simultaneously compete and collaborate: Pelaez said his team has communicated with researchers at CU and at Stanford, another award recipient, about their eye-removal research. The total funding available for the teams is $125 million, ARPA-H officials said Monday, and it will be distributed in phases, in part dependent on teams’ success. U.S. Rep. Diana DeGette, a Democrat who represents Denver in Congress, acknowledged the recent election results at the press conference Monday and pledged to continue fighting to preserve ARPA-H’s funding under President-elect Donald Trump’s administration. The effort to cure blindness, Washington joked, was “biblical” in its enormity — a reference to the Bible story in which Jesus cures a blind man. She and others also likened it to a moonshot, meaning the effort to successfully put Neil Armstrong and Buzz Aldrin on the moon nearly 50 years ago. If curing blindness is similar to landing on the moon, then the space shuttle has already left the launchpad, Washington said. “We have launched,” she said, “and we are on our trajectory.”
NOTE: Late games between Daniel Boone and Providence Academy and Chuckey-Doak versus David Crockett were still in progress at press time. Recaps of those games can be seen online at johnsoncitypress.com and timesnews.net or in the next editions of the Johnson City Press and Kingsport Times News. Clinton was able to keep the pressure on University High on Tuesday afternoon. Pressing throughout four quarters, the Dragons defeated the Bucs 64-40 in the opening boys’ game of the 35th annual Hardee’s Classic basketball tournament at David Crockett High School. It was the strategy which University High coach Herman Rice and staff figured the Dragons (2-1) would employ. But, it proved too much for the Bucs (1-2) to overcome. Clinton led 19-12 after one quarter and 34-22 at halftime. “Their intensity was the way a basketball team should play and we didn’t meet the challenge,” Herman Rice said. “The disappointing thing is our senior group has played in the state tournament and they’ve seen presses. Nothing against Clinton, but we’ve seen presses like that and had no trouble with them. I was shocked we didn’t handle it well.” Bryson Maddux led the bigger and stronger Clinton team with 19 points. Carson Richardson reached double figures with 10 points. Ben Tackett netted nine points and Braylon Hayden was next with eight points. Brady Weems was the leading scorer for University High with 13 points and Andrew Cole finished with 10 points. Knox Poston ended with eight points. Rice played his reserves extensively and was pleased what he saw out of them. Cash Paysinger had just four points, but impacted the game with his tough play and battling inside for rebounds. “We were really impressed with the second group,” Rice said. “That’s the kind of effort we have to have from everybody. Cash took five charges. He will sacrifice his body and will do anything you ask him for the team.” South Greene 62, Cocke County 53 The defending tournament champion Rebels began their defense of their title with the victory over the Fighting Cocks. South Greene led 35-24 at the half before Cocke County cut the lead to four to start the third quarter. The Rebels pushed the lead to 48-38 at the end of three quarters and led by double digits for most of the second half. Chandler Gamble led South Greene with 21 points. Jase Roderick posted 15 for the Rebels and Gavin Dyer tallied a dozen. Kyler Hayes paced Cocke County with 11 points. Maddox Holt, Ethan Fine and Spencer Moore Jr. each scored 10.
Wall Street stocks, bitcoin take breath from record highs ahead of US jobs data
The Policy Research Working Paper authored by researchers from the World Bank, Central European University, and the Government Transparency Institute, explores the impact of green public procurement (GPP) on governance and economic efficiency. This study, covering 2011 to 2019, investigates Bulgaria’s unexpected progress in GPP, a country that faces governance challenges like high corruption risks and limited competition in public procurement. The findings highlight how integrating sustainability criteria into public spending can improve competition, reduce corruption risks, and enhance economic outcomes, even in challenging environments. Green Public Procurement’s Growing Role GPP constituted 10-20% of Bulgaria’s total public procurement spending during the study period, significantly higher than previous estimates. By analyzing over 148,000 contracts, researchers found that green criteria were most often embedded in product descriptions and technical specifications rather than in bid evaluation criteria. This marks a shift in how sustainability is integrated into public procurement, focusing more on what is procured (e.g., renewable energy or electric vehicles) than on how bids are scored. The findings challenge traditional views of GPP as a peripheral policy tool and underscore its growing role as a core component of procurement strategies aimed at sustainability. Fostering Competition Through Innovation One of the most significant outcomes of GPP is its ability to foster competition in markets traditionally dominated by entrenched networks. The study found that GPP increased the participation of new firms in public procurement by 3-7 percentage points, particularly those from outside the procuring authority’s locality. This broader participation disrupts monopolistic practices and opens opportunities for diverse market players. Additionally, green contracts were associated with a reduction in single-bid tenders by 0.6-1.5 percentage points, a metric often linked to corruption. By incentivizing market entry and increasing competition, GPP effectively reduces the concentration of procurement markets and encourages transparency. Reducing Corruption Risks The study highlights GPP’s role in reducing corruption risks in public procurement. Contracts that incorporated green criteria were less likely to be awarded through non-competitive processes. The likelihood of single-bid contracts, a red flag for corruption, decreased significantly under GPP frameworks. Furthermore, green procurement fosters more open and transparent procurement procedures, challenging the dominance of entrenched players and limiting opportunities for collusion. This alignment of sustainability with integrity offers a compelling argument for scaling GPP as a means to tackle corruption, especially in countries with governance challenges. Boosting Productivity and Economic Efficiency Beyond governance improvements, GPP significantly enhances economic outcomes by channeling public resources to more productive firms. The analysis revealed that firms awarded GPP contracts demonstrated 14% higher labor productivity compared to those awarded non-green contracts. This productivity differential rose to 19% in low-corruption-risk GPP contracts. These findings suggest that GPP attracts firms with superior technology and management capabilities, enabling them to meet the stringent environmental requirements of green contracts. This alignment between environmental and economic goals underscores GPP’s potential to support both sustainability and economic growth. Challenges and Future Implications Despite its benefits, GPP faces implementation challenges, including high upfront costs, complexity in procurement processes, and limited awareness among procurement professionals. These barriers can hinder its broader adoption, especially in less developed markets. Moreover, GPP often interacts with other policies, such as social and environmental regulations, making it difficult to isolate its specific impacts. Nevertheless, the study’s findings highlight the transformative potential of GPP, particularly when implemented strategically and consistently. By fostering market development and encouraging innovation, GPP can create long-term benefits that extend beyond the immediate procurement process. A Path Toward Sustainable Development The study establishes that GPP serves as a tool for achieving environmental goals and strengthens governance and economic efficiency. By encouraging competition, reducing corruption risks, and promoting productivity, GPP demonstrates its value as a comprehensive policy mechanism. The findings suggest that even in governance-challenged environments like Bulgaria, GPP can drive meaningful change. Policymakers are encouraged to invest in sustainable procurement practices, which, over time, can build markets for environmentally friendly products, foster innovation, and amplify economic benefits. The Bulgarian case provides a compelling model for other nations seeking to integrate sustainability into their public procurement systems, proving that green choices in public spending can lead to a less corrupt, more competitive, and economically dynamic future.Investors with a lot of money to spend have taken a bullish stance on Regeneron Pharmaceuticals REGN . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with REGN, it often means somebody knows something is about to happen. So how do we know what these investors just did? Today, Benzinga 's options scanner spotted 12 uncommon options trades for Regeneron Pharmaceuticals. This isn't normal. The overall sentiment of these big-money traders is split between 58% bullish and 41%, bearish. Out of all of the special options we uncovered, 8 are puts, for a total amount of $735,359, and 4 are calls, for a total amount of $167,575. Expected Price Movements After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $700.0 and $800.0 for Regeneron Pharmaceuticals, spanning the last three months. Insights into Volume & Open Interest Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you track the liquidity and interest for Regeneron Pharmaceuticals's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Regeneron Pharmaceuticals's whale activity within a strike price range from $700.0 to $800.0 in the last 30 days. Regeneron Pharmaceuticals Call and Put Volume: 30-Day Overview Largest Options Trades Observed: Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume REGN PUT SWEEP BEARISH 05/16/25 $78.7 $78.3 $78.7 $780.00 $173.0K 102 22 REGN PUT SWEEP BULLISH 12/19/25 $60.0 $58.3 $58.3 $700.00 $104.9K 210 103 REGN PUT SWEEP BULLISH 12/19/25 $60.0 $57.9 $57.9 $700.00 $98.4K 210 103 REGN PUT SWEEP BULLISH 12/19/25 $60.0 $57.9 $57.9 $700.00 $92.6K 210 103 REGN PUT SWEEP BULLISH 12/19/25 $60.0 $58.3 $58.3 $700.00 $81.6K 210 103 About Regeneron Pharmaceuticals Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia). In light of the recent options history for Regeneron Pharmaceuticals, it's now appropriate to focus on the company itself. We aim to explore its current performance. Regeneron Pharmaceuticals's Current Market Status With a trading volume of 444,007, the price of REGN is down by -0.82%, reaching $743.4. Current RSI values indicate that the stock is may be oversold. Next earnings report is scheduled for 66 days from now. What The Experts Say On Regeneron Pharmaceuticals Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $1116.2. Turn $1000 into $1270 in just 20 days? 20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access .* An analyst from Truist Securities has decided to maintain their Buy rating on Regeneron Pharmaceuticals, which currently sits at a price target of $1126. * An analyst from Citigroup downgraded its action to Neutral with a price target of $895. * Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Regeneron Pharmaceuticals with a target price of $1215. * Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Regeneron Pharmaceuticals with a target price of $1195. * In a cautious move, an analyst from Wolfe Research downgraded its rating to Outperform, setting a price target of $1150. Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely. If you want to stay updated on the latest options trades for Regeneron Pharmaceuticals, Benzinga Pro gives you real-time options trades alerts. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Former FBI Informant Accused of Lying About Bidens Indicted on Tax ChargesA post shared on social media purports that Florida Governor Ron DeSantis can fill the House of Representatives vacancy of Florida Republican Rep. Matt Gaetz. Verdict: False The seat must be filled by a special election process. Fact Check: The House Ethics Committee did not reach a decision on whether to release the investigation into the allegations made against Gaetz, several Senate members stated they want to review the report, NBC News reported. Sexual misconduct allegations were made against Geatz, who was recently announced as President-elect Donald Trump’s nominee for Attorney General, according to the outlet. A post shared on X, formerly known Twitter, purports that DeSantis is prepared to replace Gaetz’s vacant seat. The claim was made in a response tweet. The post reads, “Gaetz resigned immediately so Gov. DeSantis can fill the seat by Jan 3. Johnson has already placed a call w/ DeSantis. Clock starts.” The claim is inaccurate. A vacancy in the House of Representatives must be filled by a special election. The 17 th Amendment allows the Governors to temporarily fill Senate vacancy until a special election can occur . DeSantis is instructing the start of a special election process, which has “no timeline,” to fill Gaetz’s seat since he resigned, Wear News reported. DeSantis is considering a replacement for Marco Rubio, Fox News reported. Trump’s daughter-in-law Lara Trump has been speculated as a potential replacement. (RELATED: Is Trump Set To Make Great Britain A State?) This is not the first time misinformation surrounding Trump’s picks has circulated online. Check Your Fact recently debunked a claim Elon Musk said that Trump will do anything he tells him to.
As part of a national “moonshot” to cure blindness, researchers at the CU Anschutz Medical Campus will receive as much as $46 million in federal funding over the next five years to pursue a first-of-its-kind full eye transplantation. “This is no easy undertaking, but I believe we can achieve this together,” said Dr. Kia Washington, the lead researcher for the University of Colorado-led team, during a press conference Monday. “And in fact I’ve never been more hopeful that a cure for blindness is within reach.” The CU team was one of four in the United States that received funding awards from the federal Advanced Research Projects Agency for Health , or ARPA-H. The CU-based group will focus on achieving the first-ever vision-restoring eye transplant by using “novel stem cell and bioelectronic technologies,” according to a news release announcing the funding. The work will be interdisciplinary, Washington and others said, and will link together researchers at institutions across the country. The four teams that received the funding will work alongside each other on distinct approaches, though officials said the teams would likely collaborate and eventually may merge depending on which research avenues show the most promise toward achieving the ultimate goal of transplanting an eye and curing blindness. Dr. Calvin Roberts, who will oversee the broader project for ARPA-H, said the agency wanted to take multiple “shots on goal” to ensure progress. “In the broader picture, achieving this would be probably the most monumental task in medicine within the last several decades,” said Dr. Daniel Pelaez of the University of Miami’s Bascom Palmer Eye Institute, which also received ARPA-H funding. Pelaez is the lead investigator for that team, which has pursued new procedures to successfully remove and preserve eyes from donors, amid other research. He told The Denver Post that only four organ systems have not been successfully transplanted: the inner ear, the brain, the spinal cord and the eye. All four are part of the central nervous system, which does not repair itself when damaged. If researchers can successfully transplant the human eye and restore vision to the patient, it might help unlock deeper discoveries about repairing damage to the brain and spine, Pelaez said, as well as addressing hearing loss. To succeed, researchers must successfully remove and preserve eyes from donors and then successfully connect and repair the optical nerve, which takes information from the eye and tells the brain what the eye sees. A team at New York University performed a full eye transplant on a human patient in November 2023, though the procedure — while a “remarkable achievement,” Pelaez said — did not restore the patient’s vision. It was also part of a partial face transplant; other approaches pursued via the ARPA-H funding will involve eye-specific transplants. Washington, the lead CU researcher, said she and her colleagues have already completed the eye transplant procedure — albeit without vision restoration — in rats. The CU team will next work on large animals to advance “optic nerve regenerative strategies,” the school said, as well as to study immunosuppression, which is critical to ensuring that patients’ immune systems don’t reject a donated organ. The goal is to eventually advance to human trials. Pelaez and his colleagues have completed their eye-removal procedure in cadavers, he said, and they’ve also studied regeneration in several animals that are capable of regenerating parts of their eyes, like salamanders or zebra fish. His team’s funding will focus in part on a life-support machine for the eye to keep it healthy and viable during the removal process. InGel Therapeutics, a Massachusetts-based Harvard spinoff and the lead of a third team, will pursue research on 3-D printed technology and “micro-tunneled scaffolds” that carry certain types of stem cells as part of a focus on optical nerve regeneration and repair, ARPA-H said. ARPH-A, created two years ago, will oversee the teams’ work. Researchers at 52 institutions nationwide will also contribute to the teams. The CU-led group will include researchers from the University of Southern California, the University of Wisconsin, Indiana University and Johns Hopkins University, as well as from the National Eye Institute . The teams will simultaneously compete and collaborate: Pelaez said his team has communicated with researchers at CU and at Stanford, another award recipient, about their eye-removal research. Related Articles The total funding available for the teams is $125 million, ARPA-H officials said Monday, and it will be distributed in phases, in part dependent on teams’ success. U.S. Rep. Diana DeGette, a Democrat who represents Denver in Congress, acknowledged the recent election results at the press conference Monday and pledged to continue fighting to preserve ARPA-H’s funding under President-elect Donald Trump’s administration. The effort to cure blindness, Washington joked, was “biblical” in its enormity — a reference to the Bible story in which Jesus cures a blind man. She and others also likened it to a moonshot, meaning the effort to successfully put Neil Armstrong and Buzz Aldrin on the moon nearly 50 years ago. If curing blindness is similar to landing on the moon, then the space shuttle has already left the launchpad, Washington said. “We have launched,” she said, “and we are on our trajectory.”Affordability, carbon tax bills pass as Sask. legislature wraps until spring
It’s almost time for Spotify Wrapped. When can you expect your 2024 recap?Emera Inc. stock rises Thursday, outperforms market
Legendary drug lord Fabio Ochoa is deported to Colombia and walks free after 20 years in US prisons
Low-quality catheters supplied to Bengal govt hospitals at high price probe orderedFrom Molly Kilete, Abuja The Chief of Defence Staff (CDS), General Christopher Musa, has again called on Nigerians not to see national security as the sole responsibility of the Armed Forces. He said that the actions of the military in ensuring Nigeria’s national security account for only 30 per cent of the overall efforts required, while the remaining 70 per cent for maintaining Nigeria’s peace and security rests on the socio-economic elements of the country. The CDS made this known at the Roundtable Discussion on Nigeria’s Security and National Interest organized by organised by the National Counter Terrorism Centre Office of the National Security Adviser in conjunction with the Defence Correspondents’ Association of Nigeria. The CDS, who spoke on the theme “National Security and National Interest: A Development Journalism Approach for the Defence Beat,” noted that in a world fraught with echoes of conflict, uncertainty, security dilemmas, and ambiguous and complex geopolitical challenges, the narrative surrounding national security often emerges from a narrow lens. According to him, “It is easy to find that the focus on national security is often skewed and confined to discussions of military strength as well as the immediate threats posed by hostile state and non-state actors. “Although these views are essential, it is important that our understanding of national security is expanded to incorporate broader social, economic, and environmental elements, which are hallmarks of what is termed ‘development journalism. “In a nutshell, national security entails the protection of our nation’s core values and institutions as well as citizens from both external and internal threats, while national interest involves the broad goals and objectives guiding our nation’s actions and decisions.” Gen. Musa noted that development journalism sought to promote public awareness and understanding of defence as well as security issues while holding governments, the defence sector, and other stakeholders accountable for their actions as well as informing decision-making by policymakers and defence officials. He further stated that the adoption of a development journalism approach allows for a more active collaboration with journalists and media organisations, enabling them to play a more effective role in promoting national cohesion and stability, thereby advancing Nigeria’s national interest. “Therefore, our national security cannot and should not solely be reliant on the strength of the Armed Forces of Nigeria; rather, it should be strengthened by Nigeria’s educated, healthy, and socially cohesive population underpinned by development journalism. “More so, the development journalism approach will not only require collaboration and dialogue among stakeholders; it will also focus on people centrism in the accomplishment of Nigeria’s national interest. He said, “This approach thus resonates with my leadership concept, which is, “to nurture a professional Armed Forces of Nigeria that is people-centric, capable of meeting its constitutional responsibilities in a joint and Collaborative environment.” Gen. Musa, while noting that the defence beat should be tailored through a development journalism lens through various options available, listed some of the options to include the continuous prioritisation of human security, adoption of investigative reporting on policy impact and the real-world implications, as well as promoting dialogue, inclusivity, and stakeholders’ engagement through available fora. He therefore called for the need to advocate for sustainable practices through reporting on innovative practices in defence as well as using available data to tell the stories as evidence-based outcomes allow for a more informed public discourse. The CDS, while noting that These options will engender trust and cooperation between the military, civil society and other stakeholders and enhance contextual understanding of local dynamics for enhanced social cohesion and effective collaboration, said “Today’s occasion presents me the rare opportunity to make a statement on the critical role of the media in fostering Nigeria’s national security and defence matters, thus necessitating collaboration to further Nigeria’s national security interests.” Earlier in his address, the National Coordinator, National Counter-Terrorism Centre, Office of the National Security Adviser, Major General Adamu Laka, who commended the media for its role in security reportage, assured the media of its continuous support and collaboration to deny the terrorist publicity. According to him, “The objective of this roundtable discussion with you is to foster an open and insightful exchange of ideas. By sharing your experiences, observations, and challenges, together we aim to enhance collective understanding of the dynamics of terrorism and its evolving tactics, discover the ethical considerations of reporting on such sensitive issues, identify opportunities for collaboration between journalists, security experts, and policymakers, and have our best thoughts on the development of a national strategic communication plan and protocol for the gathering and distribution of news on terrorism and violent extremism with the hope of stemming threats to our national security and interests.”Panthers vs. Chiefs Predictions & Picks: Odds, Moneyline, Spread – Week 12
AP Sports SummaryBrief at 6:09 p.m. EST
Activists say Montreal pro-Palestinian protests have been over-policedYoung Republican and Democratic Lawmakers and Activists Receive Political Bridge-Building AwardGameStop Corp. Cl A stock outperforms competitors on strong trading dayBlue Owl Capital Inc. (NYSE:OWL) Position Increased by Natixis Advisors LLC